ARAY — Accuray Incorporated

Accuray Incorporated (ARAY) Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Net Revenue: $102.2 million, down 12% year-over-year and down 13% on a constant currency basis.
• Product Revenue: $45 million, a decline of 26% overall and 28% on a constant currency basis, primarily impacted by lower sales in China.
• Service Revenue: $57.2 million, up 4% year-over-year, indicating resilience in the service segment.
• Gross Margin: Overall gross margin decreased to 23.5% from 36.1% in the prior year, with product gross margins at 19.7% compared to 43.5% previously.
• Operating Loss: $11.6 million, compared to a profit of $4.7 million in the prior year.
• Adjusted EBITDA: Loss of $1.9 million, down from a positive $9.6 million year-over-year.
• Cash Position: Total cash and equivalents decreased to $41.9 million from $63.9 million in the previous quarter.

2. Strategic Updates and Business Highlights:

• Transformation Plan: Announced a comprehensive operational and organizational transformation aimed at improving accountability, cost control, and execution speed. This includes a 15% workforce reduction and an anticipated $25 million improvement in annualized operating profitability.
• Service Portfolio Expansion: Focus on a solutions-oriented service offering to enhance customer uptime and drive higher-margin recurring revenue.
• Distributor Partnerships: Implementing a structured management program to improve performance and support for distributors, crucial for global market reach.
• Operational Improvements: Tightened financial and operational reviews to enhance accountability and execution pace.

3. Forward Guidance and Outlook:

• Revised Revenue Guidance: Expected revenue range for fiscal 2026 is now $440 million to $450 million, down from previous guidance of $471 million to $485 million.
• Adjusted EBITDA Guidance: Revised to $22 million to $25 million, down from $31 million to $35 million.
• Long-term Goals: Targeting a high single-digit adjusted EBITDA margin run rate within nine months, with aspirations to reach double digits over the medium to long term.

4. Bad News, Challenges, or Points of Concern:

• External Headwinds: Ongoing tariffs and geopolitical instability, particularly in China, have negatively impacted demand patterns and commercial activity.
• Declining Product Margins: Product gross margins are under pressure due to tariffs, inflation, and unfavorable product mix, with expectations that margins will remain between 20% to 30% going forward.
• Cash Flow Issues: Decrease in cash reserves attributed to working capital usage and restructuring payments raises concerns about liquidity.

5. Notable Q&A Insights:

• Revenue Guidance Cut: Management clarified that the guidance reduction was primarily due to the impact of tariffs and geopolitical tensions affecting the Chinese market, which has slowed deal dynamics.
• Capital Environment: Hospital customers do not appear to be reducing capital expenditures; instead, there are indications of increased opportunities for equipment purchases.
• Service Initiatives: Emphasis on developing a tiered service offering to provide more consistent revenue streams and reduce reliance on product sales, which have been volatile.

Overall, while Accuray faces significant external challenges impacting revenue and margins, the company is actively pursuing strategic initiatives aimed at long-term growth and profitability.